Company / Shares Outstanding
Regeneron Pharmaceuticals Shares Outstanding History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shares Outstanding
113.7M
FY2025
5-year range
112.2M / 115.1M
FY2021-FY2025
Trend
+0.2%
vs FY2024
Sector context
#88 of 212
Health Care
What the data says
At 113700000.00, Regeneron Pharmaceuticals's shares outstanding ranks #125 of 212 in the Health Care sector. Shares Outstanding remained relatively stable over the past 10 years, with values between 112200000.00 and 116300000.00.
Based on SEC 10-K filings.
113700000.00 in FY2025 with a 5-year CAGR of -0.2%.
Remained stable around 113700000.00 over the past 2 years.
Health Care sector context is included.
Shares Outstanding over time
Growth rates
- 3-Year CAGR
- -0.4%
- 5-Year CAGR
- -0.2%
- 10-Year CAGR
- -
Sector benchmark
#125 of 212 in Health CareTop 58% of 212This company 113.7M Sector average 306.7M
▼
-62.9% below sector average
Key checks
Key Insights
- In FY2025, shares outstanding increased 0.2% year-over-year.
- Ranks #88 out of 212 companies in the Health Care sector.
- Peak shares outstanding was recorded in FY2018.
- Lowest shares outstanding in the period was in FY2023.
Company context
Key Data Points
- Altman Z-Score 3.03 (safe zone, above 2.9 threshold)
- Strong profit margin: 32.1%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Shares OutstandingValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | 113.7M | +0.2% |
| FY2024 | 113.5M | +1.2% |
| FY2023 | 112.2M | -2.5% |
| FY2022 | 115.1M | +0.4% |
| FY2021 | 114.6M | -0.2% |
| FY2020 | 114.8M | -0.9% |
| FY2019 | 115.9M | -0.3% |
| FY2018 | 116.3M | +0.9% |
| FY2017 | 115.2M | +1.6% |
| FY2016 | 113.4M | +1.9% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026